News brief
On 2026/5/12, X reported that UK AI drug discovery company Isomorphic Labs, led by Demis Hassabis, had raised USD 2.1 billion in Series B funding to shorten drug development cycles.
Connected profiles
Explore
Sources · 1Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
- x.com ↗Published May 12, 2026
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年5月12日，据X报道，Demis Hassabis领导的英国AI药物研发公司Isomorphic Labs完成21亿美元B轮融资，目标缩短药物研发周期。